MannKind Corporation - Common Stock — Quarterly Cash Flow (NASDAQ:MNKD) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 410.14 M411.7 M494.64 M792.18 M744.4 M Total liabilities 468.76 M466.74 M539.19 M843.2 M803.6 M Total equity -58.62 M-55.04 M-44.55 M-51.02 M-59.2 M Total liabilities & shareholders' equities 410.14 M411.7 M494.64 M792.18 M744.4 M Total debt ——109.65 M354.64 M318.72 M Net debt ——-150.38 M183.29 M184.86 M

News

MannKind At An Inflection Point: Pediatric Expansion Drives The Story (NASDAQ:MNKD)

MannKind Corporation (MNKD) Discusses FDA Approval of Afrezza for Pediatric Diabetes Patients Ages 6 and Older Transcript

Compared to Estimates, MannKind (MNKD) Q1 Earnings: A Look at Key Metrics

MannKind (MNKD) Reports Q1 Loss, Misses Revenue Estimates

Agios Pharmaceuticals (AGIO) Reports Q1 Loss, Tops Revenue Estimates

MannKind: Strategic Uncertainty Follows United Therapeutics’ Pivot (NASDAQ:MNKD)

MannKind at Barclays Healthcare Conference: Strategic Growth and Innovation

MannKind Corporation (MNKD) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

MannKind at Leerink Global Healthcare: Expanding Horizons in Pharma

MannKind presents Afrezza data at diabetes conference

MannKind settles $36.3M convertible notes with cash, shares

H.C. Wainwright cuts MannKind stock price target on Tyvaso outlook